Sonia Mazara

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

Vianney Tricou, Xavier Sáez‐Llorens, Delia Yu et al. · The Lancet · 2020 · 105 citations

Veterinary Medicine, Immunology, Pediatrics +14

Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study

Xavier Sáez‐Llorens, Vianney Tricou, Delia Yu et al. · The Lancet Infectious Diseases · 2017 · 75 citations

Medicine, Immunology, Pediatrics +16

Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic

Luis Rivera Mejía, Lourdes Peña Méndez, Ananda S Bandyopadhyay et al. · The Lancet Infectious Diseases · 2023 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17